Nav: Home

Many clinicians maintain positive attitudes toward industry marketing activities

June 21, 2010

Despite current policy trends, many clinicians continue to hold positive attitudes toward gifts from and marketing interactions with pharmaceutical and device companies, according to a report in the June issue of Archives of Surgery, one of the JAMA/Archives journals.

Relationships between clinicians and the pharmaceutical and medical device industry have received increased scrutiny in recent years, according to background information in the article. "We now know that nearly all physicians maintain some relationship with industry, beginning with near-universal exposure to pharmaceutical industry marketing during medical school," the authors write. These relationships range from drug samples and free food in the workplace to larger payments, such as reimbursement for educational meetings and conferences and speaking and consulting fees. "With greater awareness of the prevalence of these relationships has come greater interest in the potential conflict of interest that they pose, with recommendations from individuals and organizations to improve transparency and independent regulation."

The Mount Sinai School of Medicine consortium in the New York area has a policy that bans or limits marketing-related interactions between physicians and industry. However, the effectiveness of such policies remains uncertain, write Deborah Korenstein, M.D., of Mount Sinai School of Medicine, and colleagues, who conducted a survey of faculty and trainees in the 11 hospitals in the system in 2008.

A total of 590 clinicians and medical students completed the survey (response rate, 67 percent), of which 59.5 percent were male, 39 percent were attending physicians and 23.7 percent of the non-students were from surgical specialties. Attitudes toward industry and gifts were generally positive; 72.2 percent of participants found sponsored lunches appropriate. "Notably, many participants [74.6 percent] found large gifts unacceptable and, like participants in previous surveys, believed that other physicians were more likely to be influenced by gifts and food from industry than they were," the authors write.

Surgeons and trainees tended to have more positive attitudes toward industry than others and were more likely to deem some gifts--including industry funding of residencies and travel expenses for attending lectures--acceptable. Pediatricians generally held less favorable attitudes toward industry. Non-attending physicians held more positive attitudes toward receiving meals, textbooks and medication samples.

A total of 54.2 percent of the clinicians were familiar with their institution's policy toward industry interactions, and those who were unfamiliar held more positive attitudes toward such interactions. "Our findings suggest the importance of physician education about the influence of industry, particularly for trainees and surgical specialists who may be less aware of the influence of industry and who may in fact be governed through their specialty bodies by more permissive guidelines. However, large changes in physician attitudes are likely to require shifts in the cultural environment of medicine. If physician attitudes become congruent with the attitudes of the public, the medical profession may be viewed as part of the solution instead of part of what the nation at large perceives to be a problem."
-end-
(Arch Surg. 2010;145[6]:570-577. Available pre-embargo to the media at www.jamamedia.org.)

Editor's Note: Data collected for this work was partially supported by the Attorney General Prescriber Education Grant Program administered by the state of Oregon. Senior author Dr. Ross is supported by a National Institute on Aging grant and by the American Federation of Aging Research through the Paul B. Beeson Career Development Award Program. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

The JAMA Network Journals

Related Pharmaceutical Articles:

Domino effect in pharmaceutical synthesis
Chemists at Friedrich-Alexander Universität Erlangen-Nürnberg (FAU) headed by Prof. Dr.
MEDLINE indexes Pharmaceutical Nanotechnology
Pharmaceutical Nanotechnology, an important journal published by Benthm Science, is accepted to be included in MEDLINE.
Pharmaceutical companies are profiting from rare diseases
Incentives intended to stimulate the development of more treatments for rare diseases are being exploited to boost the profits of pharmaceutical companies, new research led by Bangor University shows.
Molecular flexibility shown to help pharmaceutical drugs bind to their targets
Scientists have discovered an alternative way to create a stronger binding between pharmaceutical drugs and the part of the body they are targeting -- a development that can be used to fight a variety of diseases, including breast cancer.
Pharmaceutical industry-sponsored meals associated with higher prescribing rates
Accepting a single pharmaceutical industry-sponsored meal was associated with higher rates of prescribing certain drugs to Medicare patients by physicians, with more, and costlier, meals associated with greater increases in prescribing, according to an article published online by JAMA Internal Medicine.
Why pharmaceutical firms may prefer to invest in drugs over vaccines
When it comes to addressing disease, many industry observers and public health advocates believe that pharmaceutical companies prefer to invest in drugs rather than vaccines, as preventives are perceived to be inherently less profitable.
Pharmaceutical company performance improves when innovation and execution align
A study measuring the impact of pharmaceutical commercial operations on company performance finds that strategic investment in commercial innovation linked with an aligned and responsive culture of execution can produce positive results.
Breakthrough improves method for synthesizing cyanohydrins as pharmaceutical precursors
A research group led by Dr. Kazuaki Ishihara, a professor at Nagoya University, has established a new method of chemically modifying ketones in a way that ensures that optically active cyanohydrins are obtained, enabling efficient production of pharmaceutical precursors at a high yield and with good selectivity.
Pharmaceutical industry self-regulation of off-label drug promotion in the UK
The UK's self-regulatory approach to preventing pharmaceutical companies from promoting off-label use of their drugs detects mainly high-visibility promotional activity such as print advertising, according to a document analysis of off-label promotion rulings published this week in PLOS Medicine.
The effects of the Trans-Pacific Partnership on pharmaceutical innovation
The Trans-Pacific Partnership (TPP) is a multi-national trade agreement now being considered by 12 countries.

Related Pharmaceutical Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...